Examination of Ventavis (Iloprost) Inhalation Behavior Using the I-Neb AAD System in Patients With Pulmonary Arterial Hypertension When Switching the Iloprost Nebulizer Solution for Inhalation From 10 μg/mL (V10) to 20 μg/mL (V20)

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

September 15, 2016

Primary Completion Date

November 15, 2016

Study Completion Date

January 24, 2017

Conditions

Hypertension, Pulmonary

Interventions

DRUG

Iloprost,(Ventavis, BAYQ6256)

Ventavis (Iloprost) nebulizer solution for inhalation as 10 μg/mL (V10) and 20 μg/mL (V20).

DEVICE

I-Neb AAD system

Nebulizer, allows digital recording of inhalation data such as doses, inhalations per day and duration of inhalation (per day) etc.

Trial Locations (1)

Many Locations